Azitra prices private placement financing of up to USD 31.4 million

Reuters
19 hours ago
Azitra prices private placement financing of up to USD 31.4 million
  • Azitra entered into a securities purchase agreement for a private placement with gross proceeds of up to USD 31.4 million, including initial gross proceeds of USD 10.5 million.
  • The financing includes 10,470 shares of Series A convertible preferred stock priced at USD 1,000 per share.
  • Investors also received Series B warrants and Series C warrants to purchase up to 85,101,201 shares of common stock each, with an exercise price of USD 0.123 per share.
  • Series A preferred shares are expected to automatically convert into about 8,129 common shares per preferred share, subject to stockholder approval and ownership limits.
  • The company said the securities were issued under exemptions from registration requirements and it plans to register the resale of shares issuable upon conversion and warrant exercise.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Azitra Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202603191313PR_NEWS_USPR_____NY14760) on March 19, 2026, and is solely responsible for the information contained therein.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10